American Sands Energy (AMSE) 10-K 30 Jun 14 2014 FY Annual report Financial data

Document_and_Entity_Informatio

Document and Entity Information (USD $)	12 Months Ended
	Mar. 31, 2014	Jun. 24, 2014	Dec. 31, 2013
Document And Entity Information	'	'	'
Entity Registrant Name	'American Sands Energy Corp.	'	'
Entity Central Index Key	'0001432001	'	'
Document Type	'10-K	'	'
Document Period End Date	31-Mar-14	'	'
Amendment Flag	'false	'	'
Current Fiscal Year End Date	'--03-31	'	'
Is Entity a Well-known Seasoned Issuer?	'No	'	'
Is Entity a Voluntary Filer?	'No	'	'
Is Entity's Reporting Status Current?	'Yes	'	'
Entity Filer Category	'Smaller Reporting Company	'	'
Entity Public Float	'	'	$16,298,542
Entity Common Stock, Shares Outstanding	'	31,048,197	'
Document Fiscal Period Focus	'FY	'	'
Document Fiscal Year Focus	'2014	'	'

Consolidated_Balance_Sheets

Consolidated Balance Sheets (USD $)	Mar. 31, 2014	Mar. 31, 2013
Current assets:	'	'
Cash	$2,006,007	$59,981
Receivables	0	207,046
Prepaid and other current assets	255,498	95,781
Related-party receivable	0	22,324
Total current assets	2,261,505	385,132
Property and equipment, net	518	1,922
Other assets	38,200	306,640
Total assets	2,300,223	693,694
Current liabilities:	'	'
Accounts payable	177,799	457,855
Accrued expenses	108,370	1,553,106
Note payable	2,228	0
Total current liabilities	288,397	2,010,961
Convertible notes payable, net of discount $0 and $352,317, respectively	0	1,417,115
Related-party convertible notes payable, net of discount of $0 and $109,979, respectively	0	1,714,274
Mineral lease payable	0	14,640
Derivative liability	109,421	0
Total liabilities	397,818	5,156,990
Commitments and contingencies	'	'
Stockholders' deficit:	'	'
Preferred stock	0	0
Common stock, $.001 par value: 200,000,000 shares authorized; 30,935,467 and 28,990,715 shares and outstanding, respectively	30,935	28,991
Additional paid-in capital	16,421,288	6,706,565
Deficit accumulated during the development stage	-14,554,230	-11,198,852
Total stockholders' equity (deficit)	1,902,405	-4,463,296
Total liabilities and stockholders' equity (deficit)	2,300,223	693,694
Series A Preferred Stock [Member]	'	'
Stockholders' deficit:	'	'
Preferred stock	4,412	0
Total stockholders' equity (deficit)	$4,412	$0

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Discount on convertible notes payable	$0	$352,317
Discount on related-pary convertible notes payable	$0	$109,979
Stockholders' deficit:	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	5,250,000	5,250,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value (in Dollars per share)	$0.00	$0.00
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	30,935,467	28,990,715
Common stock, shares outstanding	30,935,467	28,990,715
Series A Preferred Stock [Member]	'	'
Stockholders' deficit:	'	'
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	4,750,000	4,750,000
Preferred stock, shares issued	4,412,120	0
Preferred stock, shares outstanding	4,412,120	0

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Income Statement [Abstract]	'	'	'
Revenues	$0	$0	$0
Operating expenses:	'	'	'
General and administrative	2,000,478	1,678,079	10,162,080
Mineral lease	179,069	212,918	1,713,294
Research and development	923,774	220,406	1,580,588
Total operating expenses	3,103,321	2,111,403	13,455,962
Loss from operations	-3,103,321	-2,111,403	-13,455,962
Other income (expense):	'	'	'
Interest expense	-386,848	-557,538	-1,452,963
Loss on extinguishment of debt	-252,158	0	-252,158
Gain on derivative	388,152	0	388,152
Interest income	0	0	22,985
Other income	0	200,000	198,000
Total other income (expense)	-250,854	-357,538	-1,095,984
Loss before provision for income taxes	-3,354,175	-2,468,941	-14,551,946
Provision for income taxes	-1,203	-131	-2,284
Net loss	-3,355,378	-2,469,072	-14,554,230
Less: Cumulative preferred stock dividends	-73,600	0	-73,600
Net loss attributable to common stockholders	($3,428,978)	($2,469,072)	($14,627,830)
Net loss per common share - basic and diluted	($0.12)	($0.09)	'
Weighted average common shares outstanding - basic and diluted	29,520,636	28,990,715	'

Consolidated_Statements_of_Sto

Consolidated Statements of Stockholders Equity (Deficit) (USD $)	Series A Preferred	Common Stock	Additional Paid-In Capital	Deficit Accumulated During the Development Stage	Total
Beginning balance, amount at Mar. 31, 2012	$0	$27,677	$4,811,313	($8,729,780)	($3,890,790)
Beginning balance, shares at Mar. 31, 2012	0	27,676,960	'	'	'
Shares used to satisfy deposits to purchase common stock net of commissions paid, shares	'	634,796	'	'	'
Shares used to satisfy deposits to purchase common stock net of commissions paid, amount	'	635	709,579	'	710,214
Common stock issued for cash, net of commissions paid, shares issued	'	454,985	'	'	'
Common stock issued for cash, net of commissions paid, amount	'	455	491,564	'	492,019
Common stock issued for services, shares issued	'	223,974	'	'	'
Common stock issued for services, amount	'	224	257,276	'	257,500
Share-based compensation	'	'	302,780	'	302,780
Debt discount for related party notes payable	'	'	134,053	'	134,053
Loss on conversion of convertible debt exchanged for preferred stock	'	'	'	'	0
Preferred stock units issued for related-party debt, amount	'	'	'	'	0
Accounts payable obligations settled with common stock, amount	'	'	'	'	0
Payroll obligations settled with common stock, amount	'	'	'	'	0
Related party debt exchanged for debt exchange warrants	'	'	'	'	0
Other common stock warrants issued for financing services	'	'	'	'	0
Other common stock warrants issued for research and development	'	'	'	'	0
Issuance of new warrants in connection with former convertible note holders	'	'	'	'	0
Net loss	'	'	'	-2,469,072	-2,469,072
Ending balance, amount at Mar. 31, 2013	0	28,991	6,706,565	-11,198,852	-4,463,296
Ending balance, shares at Mar. 31, 2013	0	28,990,715	'	'	'
Common stock issued for services, shares issued	'	25,000	'	'	'
Common stock issued for services, amount	'	25	10,475	'	10,500
Share-based compensation	'	'	367,691	'	367,691
Shares issued for related-party debt, shares issued	'	535,704	'	'	'
Shares issued for related-party debt, amount	'	535	226,783	'	227,318
Proceeds from issuance of preferred stock units, shares issued	2,596,054	'	'	'	'
Proceeds from issuance of preferred stock units, amount	2,596	'	3,631,881	'	3,634,477
Preferred stock units issued for convertible debt, shares issued	1,438,739	'	'	'	'
Preferred stock units issued for convertible debt, amount	1,439	'	1,924,208	'	1,925,647
Loss on conversion of convertible debt exchanged for preferred stock	'	'	88,587	'	88,587
Preferred stock units issued for related-party debt, shares issued	93,643	'	'	'	'
Preferred stock units issued for related-party debt, amount	94	'	131,007	'	131,101
Preferred stock units issued for stock offering costs, shares issued	69,399	'	'	'	'
Preferred stock units issued for stock offering costs, amount	69	'	-69	'	'
Preferred stock units issued for research and development, shares issued	214,285	'	'	'	'
Preferred stock units issued for research and development, amount	214	'	299,786	'	300,000
Derivative relating to preferred stock down-round protection rights	'	'	-497,573	'	-597,573
Common stock issued for prepaid stock offering costs, shares issued	'	375,000	'	'	'
Common stock issued for prepaid stock offering costs, amount	'	375	130,875	'	131,250
Payroll obligations exchanged for debt exchange warrants	'	'	1,049,350	'	1,049,350
Accounts payable obligations settled with common stock, shares issued	'	483,333	'	'	'
Accounts payable obligations settled with common stock, amount	'	483	249,684	'	250,167
Payroll obligations settled with common stock, stock issued	'	525,715	'	'	'
Payroll obligations settled with common stock, amount	'	526	183,474	'	184,000
Related party debt exchanged for debt exchange warrants	'	'	1,462,651	'	1,462,651
Other common stock warrants issued for financing services	'	'	445,000	'	445,000
Other common stock warrants issued for research and development	'	'	201,250	'	201,250
Issuance of new warrants in connection with former convertible note holders	'	'	83,525	'	83,525
Series A preferred stock offering costs	'	'	-273,862	'	-273,862
Net loss	'	'	'	-3,555,378	-3,355,378
Ending balance, amount at Mar. 31, 2014	$4,412	$30,935	$16,421,288	($14,554,230)	$1,902,405
Ending balance, shares at Mar. 31, 2014	4,412,120	30,935,467	'	'	'

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Cash flows from operating activities:	'	'	'
Net loss	($3,355,378)	($2,469,072)	($14,554,230)
Adjustments to reconcile net loss to net cash used in operating activities:	'	'	'
Depreciation	1,404	336	7,466
Gain on disposal of property and equipment	0	0	-49
Loss on extinguishment of debt	252,158	0	252,158
Gain on derivative liability	-388,152	0	-388,152
Accretion of debt discount	267,224	341,110	911,544
Straight-line of mineral lease payable	-14,640	-19,519	0
Stock issued for services	10,500	57,500	68,000
Stock-based compensation expense	367,691	302,780	1,887,479
Warrants issued for research and development	201,250	0	201,250
Stock offering costs for aborted offerings	279,908	0	331,250
Warrants issued for financing costs	445,000	0	445,000
Warrants issued to convertible note holders	83,525	0	83,525
Series A preferred stock units issued for research and development	300,000	'	300,000
Special warrants issued as payment for leases	0	0	188,160
Notes payable issued in payment for leases	0	0	126,840
(Increase) decrease in operating assets:	'	'	'
Receivables	207,046	175,454	0
Prepaid and other current assets	-159,717	141,912	-255,498
Related-party receivable	22,324	-22,324	0
Reclamation deposit	0	-19,065	-19,065
Increase (decrease) in operating liabilities:	'	'	'
Accounts payable	-63,389	-78,954	394,466
Accrued expenses	-211,386	330,656	3,030,706
Accrued interest on convertible debt and note payable	118,790	216,423	462,642
Net cash used in operating activities	-1,635,842	-1,042,763	-6,526,508
Cash flows from investing activities:	'	'	'
Acquisition of property and equipment	0	0	-8,524
Mine permitting costs	-19,135	0	-19,135
Disposal of property and equipment	0	0	588
Net cash used in investing activities	-19,135	0	-27,071
Cash flows from financing activities:	'	'	'
Proceeds from issuance of notes payable	19,610	0	456,610
Proceeds from issuance of convertible notes payable	150,000	0	895,000
Proceeds from issuance of preferred stock units	3,360,615	0	3,360,615
Proceeds from issuance of related-party notes payable	53,000	74,000	152,000
Proceeds from issuance of common stock and special warrants	0	492,019	2,319,427
(Increase) decrease in prepaid stock offering costs	138,917	-87,575	0
Increase in deposits for purchase of common stock	0	0	710,214
Net cash received in reverse merger	0	0	852,759
Principal and interest payments on notes payable	-121,139	0	-187,039
Net cash provided by financing activities	3,601,003	478,444	8,559,586
Net increase (decrease) in cash	1,946,026	-564,319	2,006,007
Cash, beginning of the period	59,981	624,300	0
Cash, end of the period	2,006,007	59,981	2,006,007
Supplemental disclosures of cash flow information:	'	'	'
Interest paid	29,282	0	41,435
Income taxes paid	200	100	1,250
Supplemental schedule of non-cash investing and financing activities:	'	'	'
Conversion of convertible notes payable to preferred stock units	1,925,647	0	1,925,647
Loss on convertible note conversion to preferred stock units	88,587	0	88,587
Conversion of related-party convertible notes payable to preferred stock units	131,101	0	131,101
Preferred stock units issued for stock offering costs	92,250	0	92,250
Conversion of notes payable to common stock	0	0	666,780
Conversion of related-party notes payable to common stock	227,319	0	227,319
Convertible note issued for accrued expenses	0	0	1,660,832
Issuance of warrants associated with convertible notes payable	0	0	424,266
Common stock issued for stock offering costs	131,250	200,000	331,250
Accounts payable obligations settled with common stock	250,167	0	250,167
Discount on related-party notes payable	0	134,053	134,053
Shares issued to satisfy deposits to purchase common stock	0	710,214	710,214
Related-party convertible note payable exchanged for warrants	1,462,651	0	1,462,651
Payroll obligations settled with common stock	184,000	0	184,000
Warrants issued to satisfy payroll liabilities	1,049,350	0	1,049,350
Embedded derivative resulting from issuance of preferred stock units	$497,573	$0	$497,573

1_Description_of_Business_and_

1. Description of Business and Nature of Operations	12 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Note 1 - Description of Business and Nature of Operations	'
	American Sands Energy Corp. (“ASEC” or the “Company”) is a pre-production oil company with oil sands resources located near Sunnyside, Utah. The Company intends to mine the oil sands ore using conventional mining techniques and use a proprietary solvent to extract oil from the oil sand ore. The proprietary water-free process produces high quality bitumen, recovers nearly 100% of the solvent, requires no tailings ponds, and its only by-product is reclamation ready sand. Since inception, the Company has been engaged in the business of acquiring and developing oil sand assets and technologies used to separate the oil contained in oil sands. The Company anticipates that its primary operations will include the mining of oil sands, the separation of oil products therefrom and the sale of oil and oil by-products. The Company has not generated revenues and is a development stage company.
	The Company has acquired rights to approximately 1,760 acres of prime oil sands deposits in the Sunnyside area of Utah. Prior to January 24, 2012, the Company had licensed proprietary extraction technology with Bleeding Rock, LLC (“Bleeding Rock”), which had an exclusive license to a bitumen and hydrocarbon extraction process to separate oil and other hydrocarbons from sand, dirt and other substances. The Company’s Chief Executive Officer is the manager of Bleeding Rock and has an indirect ownership interest therein.
	Effective January 24, 2012, the Company entered into a License, Development and Engineering Agreement with Universal Oil Recovery Corp. and SRS International (the “License Agreement”) whereby the Company was granted an exclusive non-transferable license to use certain technology in its proposed business to extract bitumen from oil sands. The territory covered by the agreement includes the State of Utah and any other geographic location in which a future designated project is commenced by or through the Company. In conjunction with the License Agreement, the Company terminated its operating agreement with Bleeding Rock. On November 18, 2013, the Company entered into an Amended and Restated License, Development and Engineering Agreement with Universal Oil Recovery LLC (“Amendment”). The Amendment amends and restates the License Agreement. Pursuant to the terms of the Amendment, the previous royalties of 75% on projects outside of Utah and the minimum royalty of $1,000,000 per year on such agreements have been eliminated. Pursuant to the Amendment, the Company will now pay royalties on projects outside of Utah of 15% of the net fees (net of all costs other than general and administrative expenses) collected by the Company on any license of the technology. In addition, the $25,000 per month management fee is eliminated until a permanent financing is closed (minimum of $25,000,000), at which time the payment will be reinstated. In consideration of the amendment, the Company issued to Universal Oil Recovery LLC (“UOR”), 575,000 warrants to purchase common stock of the Company for $0.01 per share, exercisable for ten years (see Note 11). The term of the License Agreement is for 20 years and thereafter so long as production of products using the technology is commercially and economically feasible.

2_Significant_Accounting_Polic

2. Significant Accounting Policies	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Note 2 - Significant Accounting Policies	'
	These financial statements have been prepared by the Company in accordance with U.S. generally accepted accounting principles (“US GAAP”) for annual financial information, as well as the instructions to Form 10-K. Accordingly they include all of the information and notes required by US GAAP for complete financial statements.
	The preparation of financial statements, in conformity with US GAAP, requires management to make judgments, estimates, and assumptions that could affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. The Company based its estimates and assumptions on historical experience and on various other assumptions believed to be applicable, and evaluated them on an on-going basis to ensure they remain reasonable under current conditions. Actual results could differ significantly from those estimates.
	a) Principles of Consolidation
	The condensed consolidated financial statements include the consolidated operations of American Sands Energy Corp. and its wholly owned subsidiary Green River Resources Inc. (“GRI”). All significant intercompany balances and transactions have been eliminated in consolidation.
	b) Receivables
	The Company has not yet commenced its primary operations and remains a development stage company as of March 31, 2014. As of March 31, 2013, the Company had receivables related to billings to a third-party company for certain research and development expenses incurred. At the end of each reporting period, the Company estimates its allowance for doubtful accounts based on historical information and specific facts and circumstances associated with each customer balance. All receivables outstanding as of March 31, 2013 have been fully collected.
	c) Property and Equipment
	Property and equipment consist of computers and equipment and are stated at cost and depreciated using the straight-line method over the estimated useful lives of 3 to 7 years.
	Maintenance, repairs, minor renewals and betterments, which do not extend the useful life of the asset are charged to expense as incurred. Major renewals and betterments are capitalized. The cost of property and equipment sold or otherwise disposed of and the related accumulated depreciation are removed from the accounts, and any gains or losses arising from the sale or disposal are included in the statements of operations.
	d) Mineral Leases
	In certain cases, the Company capitalizes costs related to investments in mineral lease interests on a property-by-property basis. Such costs include mineral lease acquisition costs. Costs are deferred until such time as the extent of proved developed reserves has been determined and mineral lease interests are either developed, the property sold or the mineral lease rights are allowed to lapse. To date, all exploration and lease costs have been expensed.
	e) Other Assets
	The Company capitalizes costs incurred in connection with a stock offering in other assets. These costs are netted against the proceeds of the stock offering, or are expensed when the offering is aborted.  As of March 31, 2013, $287,575 of costs had been incurred for a stock offering that were recorded in other assets. The Company did not have any remaining stock offering costs recorded as of March 31, 2014.
	During the year ended March 31, 2014, the Company capitalized $19,135 of costs associated with its mine permitting. There were no mine permitting costs recorded as of March 31, 2013.
	As of March 31, 2014 and 2013, the Company has $19,065 of restricted cash that has been paid as part of a reclamation bond related to the Company’s planned mining activities.
	f) Income Taxes
	The Company applies the guidance in ASC 740, Income Taxes, which requires an asset and liability approach for financial accounting and reporting for income taxes, and the recognition of deferred income tax assets and liabilities for the temporary differences between the financial reporting bases and tax bases of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled.
	The Company calculates its current and deferred tax provision based on estimates and assumptions that can differ from the actual results reflected in income tax returns filed during the subsequent year. Adjustments based on filed returns are recorded when identified.
	The Company recognizes the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Interest and penalties related to unrecognized tax benefits are included as a component of income tax expense.
	ASC 740 clarifies the accounting and disclosure for uncertainty in tax positions, as defined. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. As a result of the voluntary dissolution of GRC on December 31, 2011, the Company may not be able to utilize net operating loss carry-forwards generated by GRC to offset future taxable income. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial position, results of operations, or cash flows. Therefore, no reserves for uncertain income tax positions have been recorded.
	g) Stock-based Compensation
	The Company uses the Black-Scholes option-pricing model to determine the fair value of stock options and warrants granted. For employee stock options, the Company records the grant-date fair value as expense over the period in which it is earned, typically the vesting period. For consultants, the fair value of the stock-based award is recorded as expense over the term of the service period, and unvested amounts are revalued using the Black-Scholes model at each reporting period. For warrants issued to lenders, the Company records the grant-date fair value of the warrants, and any resulting beneficial conversion feature for convertible debt, as a debt discount. The discount is then amortized over the term of the convertible debt as non-cash interest expense.
	h) Net Loss Per Common Share
	Basic earnings or loss per common share is computed on the basis of the weighted average number of shares outstanding during the periods. Diluted earnings or loss per common share is calculated on the basis of the weighted average number of common shares outstanding during the period plus the effect of potential dilutive shares during the period. Potential dilutive shares include preferred stock, outstanding stock options and warrants and convertible debt instruments. For periods in which a net loss is reported, potential dilutive shares are excluded because they are antidilutive. Therefore, basic loss per common share is the same as diluted loss per common share for the years ended March 31, 2014 and 2013. As of March 31, 2014 and 2013, the Company had cumulative, undeclared, dividends that had not been accrued as of the Company’s fiscal year ends related to its preferred stock of $73,600 and $0, respectively, which were added to net loss on the consolidated statement of operations in order to calculate net loss per common share based on the Company’s net loss attributable to common stockholders.
	i) Research and Development
	The Company continues to develop additional technology related to its proprietary bitumen extraction process. To date, the Company has expensed costs associated with developing its technology as research and development costs. For the years ended March 31, 2014 and 2013, the Company incurred costs of $923,774 and $220,406, respectively, for research and development of its technologies.
	j) Concentrations of Risk
	Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash. Cash is placed on deposit in major financial institutions in the United States. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are financially sound and, accordingly, minimal credit risk exists with respect to these balances.
	k) Recent Accounting Pronouncements
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified effective date.  If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption.
	In June 2014, the FASB issued Accounting Standards Update (“ASU”) ASU 2014-10 Development Stage Entities. The amendments in ASU 2014-10 remove the definition of a development stage entity from Topic 915 Development Stage Entities, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. ASU 2014-10 is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company may early adopt ASU 2014-10 for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued. The Company plans to adopt ASU 2014-10 in its fiscal year ending March 31, 2015 and interim periods therein. The Company’s financial statements will be impacted by the adoption of this ASU mainly by the removal of inception-to-date information in the Company’s statements of operations, cash flows, and stockholders’ equity.
	In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers. The amendments in ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605 Revenue Recognition, and most industry-specific guidance, and creates a Topic 606 Revenue from Contracts with Customers.
	The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. The Company’s current financial statements will not be affected by the adoption of ASU 2014-09 as the Company has not recognized revenues.

3_Going_Concern

3. Going Concern	12 Months Ended
	Mar. 31, 2014
Going Concern	'
Note 3 - Going Concern	'
	The Company’s financial statements have been prepared on using the going concern assumption which contemplates the realization of assets and the liquidation of liabilities in the ordinary course of business. The Company has incurred substantial losses from operations and has negative cash flows from operating activities, which raise substantial doubt about the Company’s ability to continue as a going concern. The Company sustained a net loss for the year ended March 31, 2014 of $3,355,378 and a net loss for the year ended March 31, 2013 of $2,469,072 and has an accumulated deficit of $14,554,230, as of March 31, 2014. In addition, the Company estimates it will require approximately $75,000,000 in capital to commence principal operations.
	The Company intends to continue its research and development efforts, but does not have any revenues in order to finance these activities internally. As a result, the Company intends to seek financing in order to fund its operations.
	The Company has been able to meet its short-term needs primarily through loans from third parties, private placements of equity and debt securities, and deferring certain payment obligations to related parties.  The Company raised net proceeds over $3,600,000 from the sale of Series A preferred stock and has approximately $2,000,000 of cash on hand as of March 31, 2014.  The Company plans to continue to obtain additional financing through the sale of equity or debt securities in order to finance operations until it can generate positive cash flows from operating activities. The equity private placements are expected to provide the needed funds for continued operations and further research and development of the Company’s proprietary oil sand refining methods. There is no assurance that the Company will be able to obtain the additional financing that it needs to develop its technology and alleviate doubt about its ability to continue as a going concern. If the Company is able to obtain sufficient additional financing proceeds, the Company cannot be certain that this additional financing will be available on acceptable terms. To the extent the Company raises additional funds by issuing equity securities, the Company’s stockholders may experience significant dilution. Any debt financing, if available, may involve restrictive covenants that impact the Company’s ability to conduct business. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

4_Accrued_Expenses

4. Accrued Expenses	12 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Note 4 - Accrued Expenses	'
	Accrued expenses consist of the following:
		March 31,
		2014		2013
	Payroll and benefits	$	107,367	$	1,284,995
	Deferred research and development billings		–		178,931
	Mineral lease payable		–		89,180
	Other		1,003		–
	Total accrued expenses	$	108,370	$	1,553,106

5_Mineral_Leases

5. Mineral Leases	12 Months Ended
	Mar. 31, 2014
Mineral Leases	'
Note 5 - Mineral Leases	'
	During 2005, the Company acquired three oil sands mineral leases: (1) an undivided 40% interest in a 1,120-acre parcel, (2) an undivided 20% interest in the same 1,120-acre parcel, and (3) an undivided 16.666% interest in a 640-acre parcel. These leases are located in Carbon County, Utah. Effective March 31, 2013, the lease terms were extended through December 31, 2016 and the minimum annual lease payments were increased from $224,597 to $276,880.
	In 2009, a fourth lease was entered into with William G. Gibbs, a relative of the Chief Executive Officer of the Company, for an additional undivided 5% interest in the 640-acre parcel (for a total 21.666% undivided interest in the 640-acre parcel). This lease is located in Carbon County, Utah, adjacent to the 1,120-acre parcel. This lease has a 6-year life with a minimum yearly lease payment of $7,965 and, pursuant to an Addendum dated November 16, 2013, is scheduled to terminate by December 31, 2016, if the property has not reached commercial production.
	The Company’s interest in these leases is conditioned upon the payments of royalties, minimum yearly investment in development, tax payments, and other obligations to the owners of the leases. Three of our four leases are conditioned upon reaching the production stage by December 31, 2016 and the fourth lease requires production by October 2015. If the Company does not attain average productivity of at least 500 bbl/d by these dates, the interest in the leases may be terminated.
	Upon commencement of operations, each lease requires a production royalty of 10% of the market value of the minerals sold, net of applicable costs and expenses. The Company has the right, but not the obligation, to pool or unitize the leases, such that the ore mined is allocated between, and the royalties paid, on their proportionate interests. If not pooled, the owners will be paid royalties only to the extent the oil sands ore is mined on their respective properties. Through March 31, 2014, no production royalties were accrued or paid because production on these properties had not commenced. After three consecutive calendar years of production on the 1,120-acre parcel, the production royalty on the 1,120-acre parcel shall be the greater of the 10% royalty or $1,000,000 annually.
	Future minimum lease payments are as follows for the years ending:
	March 31,
	2015	$	276,880
	2016		276,880
	Total future minimum lease payments	$	553,760

6_Convertible_Notes_Payable

6. Convertible Notes Payable	12 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Note 6 - Convertible Notes Payable	'
	Through March 31, 2014, the Company had issued $1,515,000 of convertible notes payable pursuant to a $1,750,000 private offering. In connection with the terms of the $1,750,000 private offering, holders of the notes also received 100,286 warrants for each $50,000 loaned to the Company. Through March 31, 2014, the Company granted 3,038,667 warrants in connection with this offering (see Note 11). The Company recorded a debt discount related to the warrants and resulting beneficial conversion feature of $873,589. The unamortized debt discount was $0 and $352,317 as of March 31, 2014 and March 31, 2013, respectively. The warrants issued in connection with the notes expire in April 2014.
	During the year ended March 31, 2014, in conjunction with the private placement of the Company’s Series A preferred stock units (see Note 9), $1,440,000 of the convertible notes and $331,776 of accrued interest, along with 2,888,238 warrants, were cancelled and exchanged for 1,328,831 shares of Series A preferred stock together with warrants to purchase 1,328,831 shares of the Company’s common stock at $0.45 per share and 1,328,831 warrants to purchase the Company’s common stock at $0.70 per share. The shares and warrants issued included a 5% premium above what cash investors received as an inducement to convert. The Company recorded a loss of $218,658 in connection with the conversions. During the year ended March 31, 2014, the Company repaid $103,757, including $75,000 of principal and $28,757 of interest. As of March 31, 2014 and 2013, the Company had $0 and $1,417,115 of convertible notes outstanding. During the year ended March 31, 2014, the Company issued 121,259 warrants to certain convertible note holders in exchange for 121,259 of warrants issued in connection with the private placement described above.
	In May 2013, the Company borrowed a combined $150,000 from three individuals. The notes bear interest at 6%, are due by June 30, 2014 and are convertible into the Company’s common stock at the same rate as the Company completes a future offering of $2,000,000 or more. On November 7, 2013, the notes and accrued interest were converted into Series A preferred stock units, resulting in 109,908 shares of Series A preferred being issued, together with warrants to purchase 109,908 common shares at $0.45 per share and warrants to purchase 109,908 common shares at $0.70 per share (see Note 11).

7_Convertible_Note_Payable_Rel

7. Convertible Note Payable, Related Party	12 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Note 7 - Convertible Note Payable, Related Party	'
	On May 31, 2011, the Company converted $214,281 of its outstanding payable to Bleeding Rock into a 6% convertible promissory note. The note is convertible into 535,704 shares of the Company’s common stock. Effective January 1, 2013, the Company modified the terms of the note such that all of the outstanding principal which totaled $214,281 and accrued interest which totaled $20,712 were converted into a new note totaling $234,993 that is non-interest bearing. On August 20, 2013, Bleeding Rock assigned this note to two unrelated third parties, Tenacity L.P. and Kinsale Partners LLC. On October 10, 2013, the convertible promissory note was converted into 535,704 shares of the Company’s common stock in full satisfaction of the obligation.
	The Company entered into a Gross Royalty Agreement with Bleeding Rock whereby the Company is obligated to pay a royalty equal to 1.5% of the gross receipts from future projects using the technology, excluding the current project in Sunnyside, Utah. The Gross Royalty Agreement was similarly assigned to Hidden Peak.
	As of the date of the Termination Agreement, GRI owed $1,446,551 to Bleeding Rock, payable under the terms of the Operating Agreement. In connection with the termination of the Operating Agreement, GRI issued a 5% convertible promissory note to Bleeding Rock for this amount. Initially, the note was due one year from the date of the note. The note was subsequently modified to extend the payment date to April 30, 2014 and provide for conversion into shares of the Company’s common stock any time before maturity at the rate of one share for each $0.50 of principal or interest converted. Effective January 1, 2013, the Company further modified the terms of the note such that all of the outstanding principal, which totaled $1,446,551, and accrued interest, which totaled $67,965, were converted into a new note totaling $1,514,516 that is non-interest bearing. The Company imputed interest on the new note using a discount rate of 6% and recorded a debt discount of $116,047 which is amortized over the remaining life of the loan using the interest method.
	On September 30, 2013, the Company exchanged warrants to purchase 3,260,000 shares of common stock of the Company for the note held by Bleeding Rock and simultaneously canceled the note. The warrants have a 10-year term and an exercise price of $.01 (see Note 11). As of March 31, 2014 and March 31, 2013, the carrying balance of the note was $0 and $1,419,311, respectively, net of the unamortized remaining discount.
	In January 2013, the Company borrowed $74,000 from C14 Strategies, a company controlled by the Company’s former President. The note bears interest at 6% and is due and payable by the earlier of June 30, 2014 or when the Company completes a $2,000,000 equity or debt bridge financing transaction. The note is convertible into common stock of the Company upon completion of a bridge financing transaction at the same price and terms as the bridge financing. On November 7, 2013, the note and accrued interest were converted into Series A preferred stock units, resulting in 55,307 shares of Series A preferred shares being issued, together with warrants to purchase 55,307 common shares at $0.45 per share and 55,307 common shares at $0.70 per share.
	In July 2013, the Company borrowed $53,000 from Bleeding Rock, a company controlled by the Company’s CEO. The note bears interest at 6% and is due and payable by the earlier of June 30, 2014 or when the Company completes a $2,000,000 equity or debt bridge financing transaction. The note is convertible into common stock of the Company upon completion of a bridge financing transaction at the same price and terms as the bridge financing. On November 7, 2013, the note and accrued interest were converted into Series A preferred stock units, resulting in 38,336 shares of Series A preferred shares being issued, together with warrants to purchase 38,336 common shares at $0.45 per share and 38,336 common shares at $0.70 per share.

8_Derivative_Liability

8. Derivative Liability	12 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Note 8 - Derivative Liability	'
	In connection with the Company issuing its Series A preferred stock units described in Note 9, the Company recorded a derivative liability related to down-round protection provided to the preferred stockholders in the event that the Company sells its common stock at a price below $0.35 per share. With the assistance of a third-party valuation specialist, the Company valued the derivative liability pursuant to the accounting guidance of Accounting Standards Codification (“ASC”) ASC 820-10, Fair Value Measurements. As defined in ASC 820-10, fair value is based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. In order to increase consistency and comparability in fair
	value measurements, ASC 820-10 establishes a fair value hierarchy that prioritizes observable and unobservable inputs used to measure fair value into three broad levels, which are described below:
	Level 1	Quoted prices (unadjusted) in active markets that are accessible at the measurement date for assets or liabilities.
	Level 2	Other inputs that are observable directly or indirectly, such as quoted prices for similar assets and liabilities or market corroborated inputs.
	Level 3	Unobservable inputs that are used when little or no market data is available, which require the Company to develop its own assumptions about how market participants would value the assets or liabilities.
	Determining which category an asset or liability falls within the hierarchy requires significant judgment. The Company evaluates its hierarchy disclosure each quarter. Assets and liabilities measured at fair value on a recurring basis as of March 31, 2014 and March 31, 2013 are summarized as follows:
		Fair Value as of March 31, 2014
		Level 1			Level 2		Level 3		Total
	Liabilities
	Embedded derivative	$	–		$	–	$	109,421	$	109,421
			Fair Value as of March 31, 2013
			Level 1			Level 2		Level 3		Total
	Liabilities
	Embedded derivative	$	–		$	–	$	–	$	–
	The following table presents the fair value reconciliation of Level 3 liabilities measured at fair value on a recurring basis for the year ended March 31, 2014:
		Fair Value Measurements Using Significant Unobservable Inputs
		(Level 3)
		Embedded Derivative
	Beginning balance, March 31, 2013	$	–
	Issuances:
	Embedded derivatives issued in conjunction with Series A preferred stock units		497,573
	Total gains included in earnings		(388,152	)
	Ending balance, March 31, 2014	$	109,421
	Given the nature of the derivative liability, the carrying amounts of $109,421 and $0 reported in the accompanying consolidated balance sheets as of March 31, 2014 and March 31, 2013, respectively, were derived from Level 3 inputs and represent management’s best estimate of fair value.
	Key assumptions used in the valuation of the embedded derivatives using a Monte Carlo analysis methodology are as follows:
		March 31,
		2014			2013
	Threshold barrier	$	0.35			–
	Average price below $0.35 per share	$	0.22			–
	Probability of offer below $0.35 per share		3%			–
	Preferred share conversion price	$	1.4			–
	Conversion ratio		6.36			–

9_Preferred_Stock

9. Preferred Stock	12 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Note 9 - Preferred Stock	'
	In October 2013, the Company initiated a preferred stock unit offering to raise up to $2,000,000 with an option to increase the offering by an additional $500,000 based on market conditions and investor interest. Series A preferred stock holders are entitled to receive dividends of 6% and have a liquidation preference equal to $1.40 per share for each outstanding share of Series A preferred stock (as adjusted for stock splits, stock dividends and recapitalizations) plus an amount equal to declared but unpaid dividends thereon.
	In November 2013 the board of directors adopted resolutions approving a series of preferred stock designated as the “Series A Preferred Stock,” and a Certificate of Designation was filed with the state of Delaware on November 8, 2013. Under the original designation American Sands Energy Corp. (the “Company”) had authorized 3,250,000 shares of Series A Preferred Stock (the “Series A Stock”).
	On March 4, 2014, the board of directors approved a resolution increasing the total number of authorized shares of Series A Stock from 3,250,000 to 4,750,000. On March 5, 2014, the Company filed with the state of Delaware a Certificate of Designation of Series A Preferred Shares to effectuate the increase in authorized shares of Series A Stock, which constitutes an amendment of the Certificate of Incorporation of the Company. Except for the increase in the number of authorized shares, there was no change to the original rights, privileges, and preferences of the Series A Stock. Nevertheless, issuing additional shares of Series A Stock after the increase, which have a preference over the common stock with respect to dividends and in liquidation, would further limit the dollar amount of the participation of the common stock in any amounts that may be distributed by the Company in the future while such shares of Series A Stock are outstanding.
	Each unit of the offering sells for $1.40 and entitles the holder to receive one share of Series A preferred stock along with one warrant to purchase a share of the Company’s common stock at $0.45 and one warrant to purchase the Company’s common stock at $0.70 per share (hereafter, referred to as “Series A preferred stock units”).
	Each holder of Series A preferred stock has the right at any time after the date of issuance to convert their Series A preferred stock by dividing $1.40 by the Conversion Price in effect at the time for such shares. The Conversion Price is the lower of $0.35 per share or the lowest price that any additional shares of common stock were issued after the initial purchase date. Common shares issued in transactions such as granting of employee incentive options pursuant to the Company’s 2011 Long-Term Incentive Plan, shares issued in certain financings, and shares issued to acquire technology or assets do not reduce the Conversion Price. The Series A preferred stock automatically converts upon the Company completing a financing transaction of $10,000,000 or more.
	During the six months ended March 31, 2014, the Company issued a total of 4,412,120 Series A preferred stock units. The Company received net cash proceeds of $3,360,615 from selling 2,596,054 Series A preferred stock units and issued an additional 1,532,382 Series A preferred stock units in connection with conversions of convertible debt and accrued interest totaling $1,925,647 and conversions of related-party debt and accrued interest of $131,101. The Company used a portion of the proceeds to complete required test drilling at its Sunnyside site location in connection with its project permitting process and for general corporate purposes.

10_Common_Stock

10. Common Stock	12 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Note 10 - Common Stock	'
	Fiscal Year Ended March 31, 2014
	On March 31, 2014, the Company issued 525,715 shares of common stock at $0.35 per share to the Company’s CEO to satisfy past payroll obligations totaling $184,000. The board approved the issuance and issue price in August 2013.
	On March 31, 2014, the Company issued 333,333 shares of common stock at $0.35 per share to the Company’s CFO to satisfy past accounts payable obligations totaling $116,667. The board approved the issuance and issue price in August 2013.
	On March 31, 2014, the Company issued 150,000 shares of common stock at $0.89 per share to a Company controlled by the Company’s former President to satisfy accounts payable obligations totaling $133,350.
	As more fully described in Note 7, on October 10, 2013, the Company issued 535,704 shares of common stock to convert a note payable that had principal and accrued interest totaling $227,318.
	On July 1, 2013, the Company entered into a consulting agreement with Great Bear, LLC (“Great Bear”) to provide corporate, advisory, and marketing services to the Company. The agreement calls for the Company to issue Great Bear 100,000 shares of restricted common stock as consideration for the services to be provided and to pay a one-time $5,000 fee upon completion of an offering of at least $2,000,000. The term of the agreement is for one year. The Company issued 75,000 shares of common stock to Great Bear on July 15, 2013 and the balance of the shares of common stock was issued on November 6, 2013.
	Effective July 11, 2013, the Company entered into a financial advisory agreement (the “Merriman Agreement”) with Merriman Capital, Inc. ("Merriman"), a wholly owned subsidiary of Merriman Holdings, Inc. (OTCQX: MERR). The Merriman Agreement is for a 12-month period and the Company issued 300,000 shares of restricted common stock to Merriman in connection with the Series A preferred stock unit offering. Under the Merriman Agreement, Merriman will advise the Company on strategic initiatives to increase stockholder value, analyze the Company’s operating projections and market conditions and provide the Company with recommendations for the proper positioning of the Company with potential investors. Merriman will also assist the Company in raising its next round of capital. The Company has agreed that Merriman will have unlimited "piggyback" registration rights for a period of three years after the issuance of the shares at the Company's expense (provided that such rights shall not apply to a public offering of the Company’s common stock upon any underwriter’s reasonable assertion in writing that the inclusion of such stock in a public offering would materially impair the marketability of such public offering).
	Fiscal Year Ended March 31, 2013
	In March 2012, the Company initiated a private placement of units at a price of $50,000 per unit. Each unit is comprised of 43,478 shares of common stock and two-year warrants to purchase another 10,870 shares of common stock at $1.15 per share. The Company sold 634,796 shares of common stock under the private placement agreement resulting in gross proceeds of $710,214. As of March 31, 2012, none of the shares had been issued, and the shares were subsequently issued during the year ended March 31, 2013.
	During the year ended March 31, 2013, the Company sold an additional 454,985 shares of common stock under the private placement agreement resulting in gross proceeds of $492,019. As more fully described in Note 11, the Company issued 272,402 warrants during the year ended March 31, 2013 in connection with this private placement.
	During the year ended March 31, 2013, the Company issued 223,974 shares of common stock valued at $257,500 to consulting firms assisting the Company with fund raising.

11_Warrants

11. Warrants	12 Months Ended
	Mar. 31, 2014
Warrants and Rights Note Disclosure [Abstract]	'
Note 11 - Warrants	'
	The Company has issued various classes of warrants as described below:
	a)	Bridge Warrants
		In connection with the issuance of certain notes payable, the Company granted bridge warrants to the note holders. These bridge warrants give the holders the right to purchase shares of the Company’s common stock at $0.40 per share. All of the bridge warrants expired as of September 30, 2013.
	b)	Convertible Debt Warrants
		In connection with the Company’s $1,750,000 convertible note private offering (see Note 6), the Company granted warrants to the note holders. These warrants give the holders the right to purchase shares of the Company’s common stock at approximately $0.50 per share. In conjunction with the exchange of $1,440,000 of the convertible notes and $331,776 of accrued interest into Series A preferred stock units, 2,663,610 of the convertible debt warrants were returned to the Company and canceled. As of March 31, 2014 and March 31, 2013, there were 174,485 and 3,038,667 convertible debt warrants outstanding, respectively. The 174,475 warrants outstanding as of March 31, 2014 expired on April 30, 2014.
	c)	Private Placement Warrants
		In connection with the Company’s private placement of common stock initiated in 2012 (see Note 10), the Company granted warrants to the stock purchasers. These warrants give the holders the right to purchase shares of the Company’s common stock at $1.15 per share for a 2-year period. As of March 31, 2014 and March 31, 2013, there were 108,700 and 333,571 private placement warrants outstanding, respectively of which 61,169 were issued to brokers associated with the transaction. 86,960 of the warrants expired during the year ended March 31, 2014. In March 2014, the Company issued 121,259 3-year warrants to purchase the Company’s common stock at $1.15 to certain convertible note holders who converted their notes to Series A preferred stock units (see Note 9).
	d)	Debt Exchange Warrants
		On September 30, 2013, the Company exchanged warrants to purchase 3,260,000 shares of common stock of the Company for a related-party convertible note payable (see Note 7) and simultaneously canceled the note. On September 30, 2013, the Company exchanged warrants to purchase 2,260,000 shares of common stock of the Company for the outstanding payroll obligation owed to the Company’s CEO in the amount of $1,049,350. The warrants give the holders the right to purchase the Company’s common stock at $0.01 for a 10-year period. The fair value of the warrants issued in satisfaction of these liabilities was calculated using the Black-Scholes pricing model. Based on the fair value calculation, the amount of the related party convertible note payable and the amount of the outstanding payroll obligation exceeded the fair value of the warrants issued in satisfaction of these obligations. Due to the related party nature of the transaction, the Company did not record a gain on forgiveness of debt, but instead recorded the transaction as an equity transaction.
	e)	Series A Preferred Stock Warrants
		In connection with the Company’s offering of its Series A preferred stock units (see Note 9) through March 31, 2014, the Company issued 4,128,436 warrants to purchase the Company’s common stock at $0.45 and 4,128,436 warrants to purchase the Company’s common stock at $0.70 per share. The warrants have a five-year term and a cashless exercise provision.
		The Company issued 214,285 of Series A preferred stock units for research and development expenses. The issuance included the Company issuing 214,285 warrants to purchase the Company’s common stock at $0.45 and 214,285 warrants to purchase the Company’s common stock at $0.70 per share.
	f)	Broker Warrants
		In connection with the Company’s offering of its Series A preferred stock units, through March 31, 2014, the Company issued 649,578 warrants to purchase the Company’s common stock at $0.35 per share for a 5-year period. The warrants were issued to brokers associated with the Series A transactions.
	g)	Other Common Stock Warrants
		In connection with the amended License Agreement described in Note 1, the Company issued 575,000 warrants to purchase common stock of the Company at $0.01 per share. The estimated fair value of these warrants of $201,250 was recorded as research and development expense during the year ended March 31, 2014.

12_Stock_Option_Plan

12. Stock Option Plan	12 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Note 12 - Stock Option Plan	'
	In April 2011, the Company adopted the 2011 Long-Term Incentive Plan (the “2011 Plan”) which reserves for the issuance of up to 7,000,000 shares of the Company’s common stock. During the year ended March 31, 2014, the Company issued 500,000 options to directors of the Company within the 2011 Plan. The options vest over two years, have an exercise price of $0.35 per share, and expire on July 11, 2018. During the year ended March 31, 2014, the Company issued 360,000 5-year options to third party consultants who help the Company with mine permitting, accounting, and fund raising. 100,000 of these options vested immediately, while 185,000 vest over two years and the remaining 75,000 vest over three years. During the year ended March 31, 2013, the Company issued 450,000 options to officers and directors of the Company within the 2011 Plan. The options vest over four years, have an exercise price of $1.15 per share, and expire on June 15, 2017.
	The Company recorded $367,691 and $302,780 of compensation expense during the years ended March 31, 2014 and 2013, respectively, in connection with issuing the options described above. The fair value of stock options granted was determined using the Black Scholes option pricing model based on the following assumptions:
			March 31,
	Assumption			2014				2013
	Dividend yield			–				–
	Weighted average volatility			686.27%				175.45%
	Risk-free interest rate			0.99%				0.43%
	Expected life (years)			5				5
	Expected option lives were based on historical data of the Company. Expected stock price volatility was based on data from comparable public companies. The risk free interest rate was calculated using U.S. Treasury constant maturity rates similar to the expected lives of the options, as published by the Federal Reserve. The Company has no plans to declare any future dividends.
	The summary of option activity for the years ended March 31, 2014 and 2013 is presented below:
			Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Life (years)
	Balance as of March 31, 2012			3,212,500			$	0.4				5.95
	Granted			450,000				1.15				3.21
	Exercised			–				–				–
	Canceled			–				–				–
	Expired			–				–				–
	Balance as of March 31, 2013			3,662,500				0.49				3.86
	Granted			860,000				0.35				4.33
	Exercised			–				–				–
	Canceled			–				–				–
	Expired			–				–				–
	Balance as of March 31, 2014			4,522,500			$	0.47				3.95
	The weighted average grant-date fair value of options granted during the years ended March 31, 2014 and March 31, 2013 was $0.35 and $1.09, respectively.
	Outstanding and exercisable options presented by price range as of March 31, 2014 are as follows:
					Options Outstanding										Options Exercisable
									Weighted
									Average				Weighted				Weighted
					Number of				Remaining				Average		Number of		Average
	Exercise				Options				Life				Exercise		Options		Exercise
	Price				Outstanding				(Years)				Price		Exercisable		Price
	$	0.4				3,087,500				4			$	0.4		3,087,500	$	0.4
		0.5				75,000				2.46				0.5		56,250		0.5
		0.25				50,000				2.88				0.25		37,500		0.25
		1.15				450,000				3.21				1.15		300,000		1.15
		0.35				685,000				4.28				0.35		228,330		0.35
		0.35				75,000				4.39				0.35		18,750		0.35
		0.35				100,000				4.62				0.35		100,000		0.35
		$0.25-$1.15				4,522,500				3.95			$	0.47		3,828,330	$	0.45
	The estimated fair value of the Company’s stock options, less expected forfeitures, is amortized over the options’ vesting period on a straight-line basis.
	As of March 31, 2014, there was $160,091 of total unrecognized compensation cost with a weighted-average remaining vesting period of approximately 1.1 years.
	As of March 31, 2014 and 2013, the intrinsic value of outstanding and vested stock options was as follows:
			March 31,
			2014				2013
	Intrinsic value - options outstanding		$	2,038,525			$	1,895,375
	Intrinsic value - options exercisable			1,746,236				1,849,250
	Intrinsic value - options exercised			–				–

13_Income_Taxes

13. Income Taxes	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Note 13. Income Taxes	'
	Provision for income taxes consists of the following components:
		March 31,
		2014			2013
	Current	$	1,203		$	131
	Deferred		–			–
	Total	$	1,203		$	131
	Temporary differences and their related deferred income tax assets and (liabilities) are as follows:
		March 31,
		2014			2013
	Deferred income tax assets - current:
	Accrued liabilities	$	–		$	1,133,444
	Deferred income taxes - long-term:
	Net operating loss carry forward		4,844,566			2,419,684
	Total deferred income tax assets		4,844,566			3,553,128
	Valuation allowance		(4,844,566	)		(3,553,128	)
	Net deferred income tax assets	$	–		$	–
	A reconciliation of (provision) benefit for income taxes provided at the federal statutory rate (34% for fiscal years 2014 and 2013) to actual provision for income taxes is as follows:
		March 31,
		2014			2013
	Benefit for income taxes computed at federal statutory rate	$	1,140,420		$	839,440
	State income taxes, net of federal tax benefit		110,688			81,475
	Non-deductible expenses		24,591			(117,294	)
	Other		14,536			(200,602	)
	Change in valuation allowance		(1,291,438	)		(603,150	)
	Provision for income taxes	$	(1,203	)	$	(131	)
	Effective tax rate		0.11%			0.02%
	As of March 31, 2014, the Company has available for federal and state income tax purposes net operating loss carry-forwards of approximately $13,000,000, which begin to expire in 2025, that may be used to offset future taxable income, if any. Pursuant to Section 382 of the IRS code, current tax laws limit the amount of loss available to be offset against future taxable income when a substantial change in ownership occurs.  Therefore, the amount available to offset future taxable income may be limited.
	The Company has provided a full valuation allowance for the tax benefit of the operating loss carry-forwards and other deferred income tax assets due to the uncertainty regarding realization.

14_Commitments

14. Commitments	12 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Note 14 - Commitments	'
	Effective January 1, 2013, the Company modified its employment contract with its Chief Executive Officer. Pursuant to the terms of the modification, the CEO’s salary was reduced from $400,000 per year to $276,000 per year. Upon completion of a $10,000,000 or more capital raise, the CEO’s salary will increase to $400,000. On September 30, 2013, the CEO’s unpaid salary from inception through 2011 totaling $1,049,350 was exchanged for 2,260,000 warrants to purchase the Company’s common stock for $0.01 per share (see Note 11). The term of the employment agreement is in effect through December 31, 2015. On November 7, 2013, the board voted that, upon the completion of the Series A Preferred Offering, the CEO’s outstanding salary would convert into common stock at $0.35 per share. On March 31, 2014, all of the CEO’s past wages totaling $184,000 were converted into 525,715 shares of the Company’s common stock. As of March 31, 2014 and 2013, the total accrued commitment for the CEO’s past wages was $0 and $1,070,788, respectively.
	On March 31, 2011, the Company entered into an employment agreement with its Chief Operating Officer, replacing all previous employment agreements, that provides for initial compensation at an hourly rate of $175 and expense reimbursements. Upon the completion of a financing by the Company of not less than $10,000,000, his compensation will increase to $300,000 annually plus all other benefits normally provided to an employee. This employment agreement terminated May 31, 2014. A new employment agreement was entered into on June 1, 2014 (See Note 15).
	The consulting agreement dated October 1, 2011, between the Company and C14 Strategies (the “Consulting Agreement”), an entity controlled by the former President, will remain in force until a Financing Event occurs at which time it will be immediately terminated. Pursuant to the Consulting Agreement, C14 Strategies provides assistance with respect to strategic objectives of the Company. As compensation for such services, C14 Strategies is paid $10,000 per month. The contract is terminable any time on 60 days’ notice, or immediately by mutual consent. Effective March 15, 2014, the Consulting Agreement was amended whereby the agreement was extended on a month-to-month basis, the Company paid $30,000 to pay amounts owed as of December 31, 2012 and issued 150,000 shares of common stock valued at $133,500 for services rendered from January 1, 2013 through March 1, 2014. Going forward, compensation pursuant to the agreement is $5,000 per month.
	On February 16, 2012, the Company entered into an employment agreement with its Chief Financial Officer. Initially, the agreement was terminable by either party upon 30 days’ notice. Under his employment agreement, the Chief Financial Officer is entitled to receive an annual bonus of up to $120,000, at the discretion of the Board, to be paid on or before December 15th of each year. Effective January 1, 2013, the CFO’s employment agreement was modified and his annual salary was increased to $175,000. On November 7, 2013, the Board voted that, upon the completion of the Series A Preferred Offering, the CFO’s outstanding salary would convert into common stock at $0.35 per share. As of March 31, 2014 and March 31, 2013, the total accrued commitment for the CFO’s past wages was $0 and 131,250, respectively.
	Effective March 1, 2014, the Company entered into a consulting agreement for financial public relations services related to progress towards its planned mining operations. The agreement runs through March 31, 2015 and the Company pays $5,000 per month for the services.

15_Subsequent_Events

15. Subsequent Events	12 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Note 15 - Subsequent Events	'
	In April 2014, the Company received $350,000 from the issuances of 250,000 shares of its Series A preferred stock units.
	On April 22, 2014, a Series A preferred stock holder exercised 17,857 warrants resulting in the Company receiving $8,035.
	On April 23, 2014, a former convertible note holder exercised 50,143 warrants resulting in the Company receiving $25,000.
	On June 1, 2014, the Company entered into a new three-year employment agreement with its Chief Operating Officer. Pursuant to the agreement, the Company shall pay $245,000 in annual compensation until such time as the Company completes a capital raise of at least $20,000,000 at which time, the annual compensation will increase to $300,000.
	On June 10, 2014, the employment agreement for the Company’s CFO as described in Note 14 was amended to extend the period covered by the agreement through June 30, 2015. Also, the Company granted 125,000 options to the Company’s CFO. The options vest over two years, have a $0.72 per share exercise price and a 5 year term.
	On June 25, 2014, the Company entered into an agreement with a consulting firm to prepare an economic feasibility study for the Company’s planned construction and operation of a 5,000 bbl/d tar sands plant. The contract calls for the contractor to be paid on a time and materials basis with a not-to-exceed price of $152,000.

2_Significant_Accounting_Polic1

2. Significant Accounting Policies (Policies)	12 Months Ended
	Mar. 31, 2014
Accounting Policies [Abstract]	'
Principles of Consolidation	'
	a) Principles of Consolidation
	The condensed consolidated financial statements include the consolidated operations of American Sands Energy Corp. and its wholly owned subsidiary Green River Resources Inc. (“GRI”). All significant intercompany balances and transactions have been eliminated in consolidation.
Receivables	'
	b) Receivables
	The Company has not yet commenced its primary operations and remains a development stage company as of March 31, 2014. As of March 31, 2013, the Company had receivables related to billings to a third-party company for certain research and development expenses incurred. At the end of each reporting period, the Company estimates its allowance for doubtful accounts based on historical information and specific facts and circumstances associated with each customer balance. All receivables outstanding as of March 31, 2013 have been fully collected.
Property and Equipment	'
	c) Property and Equipment
	Property and equipment consist of computers and equipment and are stated at cost and depreciated using the straight-line method over the estimated useful lives of 3 to 7 years.
	Maintenance, repairs, minor renewals and betterments, which do not extend the useful life of the asset are charged to expense as incurred. Major renewals and betterments are capitalized. The cost of property and equipment sold or otherwise disposed of and the related accumulated depreciation are removed from the accounts, and any gains or losses arising from the sale or disposal are included in the statements of operations.
Mineral Leases	'
	d) Mineral Leases
	In certain cases, the Company capitalizes costs related to investments in mineral lease interests on a property-by-property basis. Such costs include mineral lease acquisition costs. Costs are deferred until such time as the extent of proved developed reserves has been determined and mineral lease interests are either developed, the property sold or the mineral lease rights are allowed to lapse. To date, all exploration and lease costs have been expensed.
Other Assets	'
	e) Other Assets
	The Company capitalizes costs incurred in connection with a stock offering in other assets. These costs are netted against the proceeds of the stock offering, or are expensed when the offering is aborted.  As of March 31, 2013, $287,575 of costs had been incurred for a stock offering that were recorded in other assets. The Company did not have any remaining stock offering costs recorded as of March 31, 2014.
	During the year ended March 31, 2014, the Company capitalized $19,135 of costs associated with its mine permitting. There were no mine permitting costs recorded as of March 31, 2013.
	As of March 31, 2014 and 2013, the Company has $19,065 of restricted cash that has been paid as part of a reclamation bond related to the Company’s planned mining activities.
Income Taxes	'
	f) Income Taxes
	The Company applies the guidance in ASC 740, Income Taxes, which requires an asset and liability approach for financial accounting and reporting for income taxes, and the recognition of deferred income tax assets and liabilities for the temporary differences between the financial reporting bases and tax bases of the Company’s assets and liabilities at enacted tax rates expected to be in effect when such amounts are realized or settled.
	The Company calculates its current and deferred tax provision based on estimates and assumptions that can differ from the actual results reflected in income tax returns filed during the subsequent year. Adjustments based on filed returns are recorded when identified.
	The Company recognizes the benefit from a tax position only if it is more-likely-than-not that the position would be sustained upon audit based solely on the technical merits of the tax position. Interest and penalties related to unrecognized tax benefits are included as a component of income tax expense.
	ASC 740 clarifies the accounting and disclosure for uncertainty in tax positions, as defined. The Company has analyzed filing positions in all of the federal and state jurisdictions where it is required to file income tax returns, as well as all open tax years in these jurisdictions. As a result of the voluntary dissolution of GRC on December 31, 2011, the Company may not be able to utilize net operating loss carry-forwards generated by GRC to offset future taxable income. The Company believes that its income tax filing positions and deductions will be sustained on audit and does not anticipate any adjustments that will result in a material adverse effect on the Company’s financial position, results of operations, or cash flows. Therefore, no reserves for uncertain income tax positions have been recorded.
Stock-based Compensation	'
	g) Stock-based Compensation
	The Company uses the Black-Scholes option-pricing model to determine the fair value of stock options and warrants granted. For employee stock options, the Company records the grant-date fair value as expense over the period in which it is earned, typically the vesting period. For consultants, the fair value of the stock-based award is recorded as expense over the term of the service period, and unvested amounts are revalued using the Black-Scholes model at each reporting period. For warrants issued to lenders, the Company records the grant-date fair value of the warrants, and any resulting beneficial conversion feature for convertible debt, as a debt discount. The discount is then amortized over the term of the convertible debt as non-cash interest expense.
Net Loss per Common Share	'
	h) Net Loss Per Common Share
	Basic earnings or loss per common share is computed on the basis of the weighted average number of shares outstanding during the periods. Diluted earnings or loss per common share is calculated on the basis of the weighted average number of common shares outstanding during the period plus the effect of potential dilutive shares during the period. Potential dilutive shares include preferred stock, outstanding stock options and warrants and convertible debt instruments. For periods in which a net loss is reported, potential dilutive shares are excluded because they are antidilutive. Therefore, basic loss per common share is the same as diluted loss per common share for the years ended March 31, 2014 and 2013. As of March 31, 2014 and 2013, the Company had cumulative, undeclared, dividends that had not been accrued as of the Company’s fiscal year ends related to its preferred stock of $73,600 and $0, respectively, which were added to net loss on the consolidated statement of operations in order to calculate net loss per common share based on the Company’s net loss attributable to common stockholders.
Research and Development	'
	i) Research and Development
	The Company continues to develop additional technology related to its proprietary bitumen extraction process. To date, the Company has expensed costs associated with developing its technology as research and development costs. For the years ended March 31, 2014 and 2013, the Company incurred costs of $923,774 and $220,406, respectively, for research and development of its technologies.
Concentrations of Risk	'
	j) Concentrations of Risk
	Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash. Cash is placed on deposit in major financial institutions in the United States. Such deposits may be in excess of insured limits. Management believes that the financial institutions that hold the Company’s cash are financially sound and, accordingly, minimal credit risk exists with respect to these balances.
Recent Accounting Pronouncements	'
	k) Recent Accounting Pronouncements
	From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) that are adopted by the Company as of the specified effective date.  If not discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on the Company’s financial statements upon adoption.
	In June 2014, the FASB issued Accounting Standards Update (“ASU”) ASU 2014-10 Development Stage Entities. The amendments in ASU 2014-10 remove the definition of a development stage entity from Topic 915 Development Stage Entities, thereby removing the distinction between development stage entities and other reporting entities from US GAAP. In addition, the amendments eliminate the requirements for development stage entities to (1) present inception-to-date information in the statements of operations, cash flows, and shareholder’s equity, (2) label the financial statements as those of a development stage entity, (3) disclose a description of the development stage activities in which the entity is engaged, and (4) disclose in the first year in which the entity is no longer a development stage entity that in prior years it had been in the development stage. The amendments also clarify that the guidance in Topic 275, Risks and Uncertainties, is applicable to entities that have not commenced planned principal operations. ASU 2014-10 is effective for annual reporting periods beginning after December 15, 2014, and interim periods therein. The Company may early adopt ASU 2014-10 for any annual reporting period or interim period for which the entity’s financial statements have not yet been issued. The Company plans to adopt ASU 2014-10 in its fiscal year ending March 31, 2015 and interim periods therein. The Company’s financial statements will be impacted by the adoption of this ASU mainly by the removal of inception-to-date information in the Company’s statements of operations, cash flows, and stockholders’ equity.
	In May 2014, the FASB issued ASU 2014-09 Revenue from Contracts with Customers. The amendments in ASU 2014-09 affects any entity that either enters into contracts with customers to transfer goods or services or enters into contracts for the transfer of nonfinancial assets unless those contracts are within the scope of other standards (e.g., insurance contracts or lease contracts). This ASU will supersede the revenue recognition requirements in Topic 605 Revenue Recognition, and most industry-specific guidance, and creates a Topic 606 Revenue from Contracts with Customers.
	The core principle of the guidance is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. To achieve that core principle, an entity should apply the following steps:
	Step 1: Identify the contract(s) with a customer.
	Step 2: Identify the performance obligations in the contract.
	Step 3: Determine the transaction price.
	Step 4: Allocate the transaction price to the performance obligations in the contract.
	Step 5: Recognize revenue when (or as) the entity satisfies a performance obligation.
	ASU 2014-09 is effective for annual reporting periods beginning after December 15, 2016, including interim periods within that reporting period. Early application is not permitted. The Company’s current financial statements will not be affected by the adoption of ASU 2014-09 as the Company has not recognized revenues.

4_Accrued_Expenses_Tables

4. Accrued Expenses (Tables)	12 Months Ended
	Mar. 31, 2014
Payables and Accruals [Abstract]	'
Accrued Expenses	'
		March 31,
		2014		2013
	Payroll and benefits	$	107,367	$	1,284,995
	Deferred research and development billings		–		178,931
	Mineral lease payable		–		89,180
	Other		1,003		–
	Total accrued expenses	$	108,370	$	1,553,106

5_Mineral_Leases_Tables

5. Mineral Leases (Tables)	12 Months Ended
	Mar. 31, 2014
Mineral Leases	'
Future minimum lease payments	'
	March 31,
	2015	$	276,880
	2016		276,880
	Total future minimum lease payments	$	553,760

8_Derivative_Liability_Tables

8. Derivative Liability (Tables)	12 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Assets and liabilities measured at fair value	'
		Fair Value as of March 31, 2014
		Level 1			Level 2		Level 3		Total
	Liabilities
	Embedded derivative	$	–		$	–	$	109,421	$	109,421
			Fair Value as of March 31, 2013
			Level 1			Level 2		Level 3		Total
	Liabilities
	Embedded derivative	$	–		$	–	$	–	$	–
Level 3 fair value reconciliation	'
		Fair Value Measurements Using Significant Unobservable Inputs
		(Level 3)
		Embedded Derivative
	Beginning balance, March 31, 2013	$	–
	Issuances:
	Embedded derivatives issued in conjunction with Series A preferred stock units		497,573
	Total gains included in earnings		(388,152	)
	Ending balance, March 31, 2014	$	109,421
Key assumptions used in the valuation of the embedded derivatives using a Monte Carlo analysis methodology	'
		March 31,
		2014			2013
	Threshold barrier	$	0.35			–
	Average price below $0.35 per share	$	0.22			–
	Probability of offer below $0.35 per share		3%			–
	Preferred share conversion price	$	1.4			–
	Conversion ratio		6.36			–

12_Stock_Option_Plan_Tables

12. Stock Option Plan (Tables)	12 Months Ended
	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]	'
Assumptions used	'
			March 31,
	Assumption			2014				2013
	Dividend yield			–				–
	Weighted average volatility			686.27%				175.45%
	Risk-free interest rate			0.99%				0.43%
	Expected life (years)			5				5
Summary of option activity	'
			Number of Shares				Weighted Average Exercise Price				Weighted Average Remaining Life (years)
	Balance as of March 31, 2012			3,212,500			$	0.4				5.95
	Granted			450,000				1.15				3.21
	Exercised			–				–				–
	Canceled			–				–				–
	Expired			–				–				–
	Balance as of March 31, 2013			3,662,500				0.49				3.86
	Granted			860,000				0.35				4.33
	Exercised			–				–				–
	Canceled			–				–				–
	Expired			–				–				–
	Balance as of March 31, 2014			4,522,500			$	0.47				3.95
Outstanding and exercisable options presented by price range	'
					Options Outstanding										Options Exercisable
									Weighted
									Average				Weighted				Weighted
					Number of				Remaining				Average		Number of		Average
	Exercise				Options				Life				Exercise		Options		Exercise
	Price				Outstanding				(Years)				Price		Exercisable		Price
	$	0.4				3,087,500				4			$	0.4		3,087,500	$	0.4
		0.5				75,000				2.46				0.5		56,250		0.5
		0.25				50,000				2.88				0.25		37,500		0.25
		1.15				450,000				3.21				1.15		300,000		1.15
		0.35				685,000				4.28				0.35		228,330		0.35
		0.35				75,000				4.39				0.35		18,750		0.35
		0.35				100,000				4.62				0.35		100,000		0.35
		$0.25-$1.15				4,522,500				3.95			$	0.47		3,828,330	$	0.45
Intrinsic value of outstanding and vested stock options	'
			March 31,
			2014				2013
	Intrinsic value - options outstanding		$	2,038,525			$	1,895,375
	Intrinsic value - options exercisable			1,746,236				1,849,250
	Intrinsic value - options exercised			–				–

13_Income_Taxes_Tables

13. Income Taxes (Tables)	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Provision for income taxes	'
		March 31,
		2014			2013
	Current	$	1,203		$	131
	Deferred		–			–
	Total	$	1,203		$	131
Deferred income taxes	'
		March 31,
		2014			2013
	Deferred income tax assets - current:
	Accrued liabilities	$	–		$	1,133,444
	Deferred income taxes - long-term:
	Net operating loss carry forward		4,844,566			2,419,684
	Total deferred income tax assets		4,844,566			3,553,128
	Valuation allowance		(4,844,566	)		(3,553,128	)
	Net deferred income tax assets	$	–		$	–
Reconcilation of income taxes	'
		March 31,
		2014			2013
	Benefit for income taxes computed at federal statutory rate	$	1,140,420		$	839,440
	State income taxes, net of federal tax benefit		110,688			81,475
	Non-deductible expenses		24,591			(117,294	)
	Other		14,536			(200,602	)
	Change in valuation allowance		(1,291,438	)		(603,150	)
	Provision for income taxes	$	(1,203	)	$	(131	)
	Effective tax rate		0.11%			0.02%

2_Significant_Accounting_Polic2

2. Significant Accounting Policies (Details Narrative) (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Accounting Policies [Abstract]	'	'	'
Property useful lives	'3 to 7 years	'	'
Stock offering costs incurred	'	$287,575	'
Capitalized mine permitting	19,135	'	19,135
Restricted cash	19,065	'	19,065
Cumulative undeclared dividends	73,600	0	73,600
Research and development costs	$923,774	$220,406	$1,580,588

3_Going_Concern_Details_Narrat

3. Going Concern (Details Narrative) (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Going Concern	'	'	'
Net loss	($3,355,378)	($2,469,072)	($14,554,230)
Accumulated deficit	-14,554,230	-11,198,852	-14,554,230
Capital required to commence its principal operations	$75,000,000	'	$75,000,000

4_Accrued_Expenses_Details

4. Accrued Expenses (Details) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Payables and Accruals [Abstract]	'	'
Payroll and benefits	$107,367	$1,284,995
Deferred research and development billings	0	178,931
Mineral lease payable	0	89,180
Other	1,003	0
Total accrued expenses	$108,370	$1,553,106

5_Mineral_Leases_Details

5. Mineral Leases (Details) (USD $)	Mar. 31, 2014
Mineral Leases	'
2015	$276,880
2016	276,880
Total future minimum lease payments	$553,760

6_Convertible_Notes_Payable_De

6. Convertible Notes Payable (Details Narrative) (USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Debt Disclosure [Abstract]	'	'
Convertible notes issued	$1,515,000	'
Warrants issued for each $50,000 loaned to the company	100,286	'
Warrants granted with offering	3,038,667	'
Debt discount/beneficial conversion feature	873,589	'
Unamortized debt discount	0	352,317
Loss on conversion of debt	-218,658	'
Repayment of convertible debt	103,757	'
Convertible debt outstanding	$0	$1,417,115

7_Convertible_Notes_Payable_Re

7. Convertible Notes Payable, Related Party (Details Narrative) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Convertible Notes Payable Related Party Details Narrative	'	'
Note payable, related party	$0	$1,419,311

8_Derivative_Liability_Details

8. Derivative Liability (Details - Liabilities at Fair Value) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Embedded derivative	$109,421	$0
Fair Value, Inputs, Level 1 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Embedded derivative	0	0
Fair Value, Inputs, Level 2 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Embedded derivative	0	0
Fair Value, Inputs, Level 3 [Member] | Fair Value, Measurements, Recurring [Member]	'	'
Embedded derivative	$109,421	$0

8_Derivative_Liability_Details1

8. Derivative Liability (Details - Fair Value Reconciliation) (USD $)	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
			Fair Value, Inputs, Level 3 [Member]
			Fair Value, Measurements, Recurring [Member]
Beginning balance	$109,421	$0	$0
Embedded derivatives issued	'	'	497,573
Gains included in earnings	'	'	-388,152
Ending balance	$109,421	$0	$109,421

9_Preferred_Stock_Details_Narr

9. Preferred Stock (Details Narrative) (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Preferred stock issued	0	0	0
Proceeds from issuance of preferred stock	$3,360,615	$0	$3,360,615
Series A Preferred Stock [Member]	'	'	'
Preferred stock issued	4,412,120	0	4,412,120

11_Warrants_Details_Narrative

11. Warrants (Details Narrative) (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Warrants issued during the year	3,038,667	'	'
Research and development costs	$923,774	$220,406	$1,580,588
Convertible Debt Warrants [Member]	'	'	'
Convertible debt warrants outstanding	174,485	3,038,667	174,485
Private Placement Warrants [Member]	'	'	'
Convertible debt warrants outstanding	108,700	333,571	108,700
Warrants issued during the year	121,259	'	'
Warrants expired during the year	86,960	'	'
Series A Preferred Stock Warrants | $0.45 per share	'	'	'
Warrants issued during the year	4,128,436	'	'
Series A Preferred Stock [Member] | Research and Development Expense [Member]	'	'	'
Warrants issued during the year	214,285	'	'
Series A Preferred Stock [Member] | $0.70 per share	'	'	'
Warrants issued during the year	4,128,436	'	'
Broker Warrants	'	'	'
Warrants issued during the year	649,578	'	'
Other Common Stock Warrants	'	'	'
Warrants issued during the year	575,000	'	'
Research and development costs	$201,250	'	'

12_Stock_Option_Plan_DetailsAs

12. Stock Option Plan (Details-Assumptions) (Options)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Options	'	'
Dividend yield	0.00%	0.00%
Weighted average volatility	686.27%	175.45%
Risk-free interest rate	0.99%	0.43%
Expected life (years)	'5 years	'5 years

12_Stock_Option_Plan_DetailsOp

12. Stock Option Plan (Details-Options Outstanding) (Options, USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Options	'	'
Number of Shares	'	'
Stock option beginning balance	3,662,500	3,312,500
Stock option granted	860,000	45,000
Stock option exercised	0	0
Stock option canceled	0	0
Stock option expired	0	0
Stock option ending balance	4,522,500	3,662,500
Weighted Average Exercise Price	'	'
Weighted average exercise price beginning balance	$0.49	$0.40
Weighted average exercise price granted	$0.35	$1.15
Weighted average exercise price exercised	'	'
Weighted average exercise price canceled	'	'
Weighted average exercise price expired	'	'
Weighted average exercise price ending balance	$0.47	$0.49
Weighted Average Remaining Life	'	'
Weighted average remaining life (years) beginning balance	'3 years 10 months 10 days	'5 years 11 months 12 days
Weighted average remaining life (years) options granted	'4 years 3 months 29 days	'3 years 2 months 16 days
Weighted average remaining life (years) ending balance	'3 years 11 months 12 days	'3 years 10 months 10 days

12_Stock_Option_Plan_DetailsOu

12. Stock Option Plan (Details-Outstanding and Exercisable) (USD $)	12 Months Ended
	Mar. 31, 2014
Exercise Price 0.40 [Member]	'
Stock options outstanding	3,087,500
Stock options outstanding weighted average remaining life (years)	'4 years
Stock options outstanding weighted average exercise price	$0.40
Stock options exerciseable	3,087,500
Stock options exerciseable weighted average exercise price	$0.40
Exercise Price 0.50 [Member]	'
Stock options outstanding	75,000
Stock options outstanding weighted average remaining life (years)	'2 years 5 months 16 days
Stock options outstanding weighted average exercise price	$0.50
Stock options exerciseable	56,250
Stock options exerciseable weighted average exercise price	$0.50
Exercise Price 0.25 [Member]	'
Stock options outstanding	50,000
Stock options outstanding weighted average remaining life (years)	'2 years 11 months 17 days
Stock options outstanding weighted average exercise price	$0.25
Stock options exerciseable	37,500
Stock options exerciseable weighted average exercise price	$0.25
Exercise Price 1.15 [Member]	'
Stock options outstanding	450,000
Stock options outstanding weighted average remaining life (years)	'3 years 3 months 16 days
Stock options outstanding weighted average exercise price	$1.15
Stock options exerciseable	300,000
Stock options exerciseable weighted average exercise price	$1.15
Exercise Price 0.35 [Member]	'
Stock options outstanding	685,000
Stock options outstanding weighted average remaining life (years)	'4 years 3 months 11 days
Stock options outstanding weighted average exercise price	$0.35
Stock options exerciseable	228,330
Stock options exerciseable weighted average exercise price	$0.35
Exercise Prices 0.35 [Member]	'
Stock options outstanding	75,000
Stock options outstanding weighted average remaining life (years)	'4 years 4 months 20 days
Stock options outstanding weighted average exercise price	$0.35
Stock options exerciseable	18,750
Stock options exerciseable weighted average exercise price	$0.35
Exercise Price 0.35 [Member]	'
Stock options outstanding	100,000
Stock options outstanding weighted average remaining life (years)	'4 years 7 months 13 days
Stock options outstanding weighted average exercise price	$0.35
Stock options exerciseable	100,000
Stock options exerciseable weighted average exercise price	$0.35
Exercise Price 0.25-1.15 [Member]	'
Stock options outstanding	4,522,500
Stock options outstanding weighted average remaining life (years)	'3 years 11 months 12 days
Stock options outstanding weighted average exercise price	$0.47
Stock options exerciseable	3,828,330
Stock options exerciseable weighted average exercise price	$0.45

12_Stock_Option_Plan_DetailsIn

12. Stock Option Plan (Details-Intrinsic value) (Options, USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Options	'	'
Intrinsic value - options outstanding	$2,038,525	$1,895,375
Intrinsic value - options exercisable	1,746,236	1,849,250
Intrinsic value - options exercised	$0	$0

12_Stock_Options_Plan_Details_

12. Stock Options Plan (Details Narrative) (Options, USD $)	12 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Options	'	'
Compensation expense	$367,691	$302,780
Weighted average grant-date fair value of options	$0.35	$1.09
Unrecognized compensation cost	$160,091	'
Weighted average vesting period	'1 year 1 month 6 days	'

13_Income_Taxes_Detailsprovisi

13. Income Taxes (Details-provision) (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'	'	'
Current income tax provision	$1,203	$131	'
Deferred income tax provision	0	0	'
Total income tax provision	$1,203	$131	$2,284

13_Income_Taxes_DetailsDeferre

13. Income Taxes (Details-Deferred income taxes) (USD $)	Mar. 31, 2014	Mar. 31, 2013
Deferred income tax assets - current:	'	'
Accrued liabilities	$0	$1,133,444
Deferred income taxes - long-term:	'	'
Net operating loss carry forward	4,844,566	2,419,684
Total deferred income tax assets	4,844,566	3,553,128
Valuation allowance	-4,844,566	-3,553,128
Net deferred income tax assets	$0	$0

13_Income_Taxes_DetailsReconci

13. Income Taxes (Details-Reconciliation) (USD $)	12 Months Ended		103 Months Ended
	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'	'	'
Benefit for income taxes computed at federal statutory rate	$1,140,420	$839,440	'
State income taxes, net of federal tax benefit	110,688	81,475	'
Non-deductible expenses	24,591	-117,294	'
Other	14,536	-200,602	'
Change in valuation allowance	-1,291,438	-603,150	'
Provision for income taxes	($1,203)	($131)	($2,284)
Effective tax rate	0.11%	0.02%	'

14_Income_Taxes_Details_Narrat

14. Income Taxes (Details Narrative) (USD $)	12 Months Ended
	Mar. 31, 2014
Income Tax Disclosure [Abstract]	'
Federal and state net operating loss carryforwards	$13,000,000
Operating loss carryforward expiration date	31-Dec-25

14_Commitments_Details_Narrati

14. Commitments (Details Narrative) (USD $)	Mar. 31, 2014	Mar. 31, 2013
CEO	'	'
Accrued salary commitment	$0	$1,070,788
CFO	'	'
Accrued salary commitment	$0	$131,250